Advertisement
News
Subscribe to Bioscience Technology News

The Lead

Nigeria Death Shows Ebola Can Spread by Air Travel

July 28, 2014 | by Heather Murdock - Associated Press - Associated Press | Comments

Nigerian health authorities raced to stop the spread of Ebola on Saturday after a man sick with one of the world's deadliest diseases brought it by plane to Lagos, Africa's largest city with 21 million people.            

TOPICS:
View Sample

FREE Email Newsletter Bioscience Technology Daily

Many People Never Grow Out of Growing Pains

July 28, 2014 11:48 am | Comments

A new research project shows that many adolescents suffer from knee pain for several years. The pain impacts both sporting activities and quality of life.                            

TOPICS:

A New Look at Stomach Cancer

July 28, 2014 11:30 am | Comments

In a massive effort to catalog the molecular causes of stomach cancer, scientists have identified four subtypes of tumors based on shared mutations and other molecular abnormalities.                    

TOPICS:

Scientists ID New Mechanism of Drug Resistance

July 28, 2014 11:24 am | Comments

Microorganisms can evade treatment by acquiring mutations in the genes targeted by antibiotics or antifungal drugs. Now, a new study has shown that microorganisms can use a temporary silencing of drug targets to gain the benefits of drug resistance without the commitment.

TOPICS:
Advertisement

Liberia president orders new anti-Ebola measures

July 28, 2014 7:22 am | by The Associated Press | Comments

Liberia President Ellen Johnson Sirleaf has closed some border crossings and ordered strict quarantines of communities affected by the Ebola outbreak. The announcement late Sunday came a day after Sirleaf formed a new taskforce charged with containing the disease, which has killed 129 people in...

Aid Group: 2 Americans have Ebola in Liberia

July 28, 2014 6:17 am | by The Associated Press | Comments

Two American aid workers have tested positive for the Ebola virus while working to combat an outbreak of the deadly disease at a hospital in Liberia, a relief group official said. Ken Isaacs, a vice president of Samaritan's Purse, told The Associated Press on Sunday that Dr. Kent Brantly, the...

5 things to know about coal trade, global warming

July 28, 2014 12:16 am | by Dina Cappiello - Associated Press - Associated Press | Comments

As the Obama administration weans the U.S. off polluting fuels blamed for global warming, energy companies have been sending more of America's unwanted energy leftovers to other parts of the world where they could create even more pollution. Here are five things to know about the issue: 1. AS...

Virus drugmaker fights pediatricians' new advice

July 28, 2014 12:15 am | by Lindsey Tanner - AP Medical Writer - Associated Press | Comments

A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the nation's leading pediatrician's group, which recommends scaling back use of the medicine. The dispute involves new guidelines from the American Academy of Pediatrics, which say medical...

Science on the job: Teachers learn from tech firms

July 26, 2014 11:22 am | by Emery P. Dalesio - Associated Press - Associated Press | Comments

A small but growing number of science and math teachers aren't spending the summer at the beach or catching up on books, they're toiling at companies, practicing the principles they teach. As American education focuses on closing the gap between the classroom and employers' needs, programs in...

Advertisement

Slow Walking Speed and Memory Complaints Can Predict Dementia

July 25, 2014 5:21 pm | by Einstein | Comments

July 25, 2014—(BRONX, NY)—A study involving nearly 27,000 older adults on five continents found that nearly 1 in 10 met criteria for pre-dementia based on a simple test that measures how fast people walk and whether they have cognitive complaints. People who tested positive for...

Total Darkness During the Night is a Key to Success of Breast Cancer Therapy

July 25, 2014 2:05 pm | Comments

Exposure to light at night, which shuts off nighttime production of the hormone melatonin, renders breast cancer completely resistant to tamoxifen, a widely used breast cancer drug, says a new study by Tulane University School of Medicine cancer researchers.

TOPICS:

Is Europe Putting Cancer Research at Risk?

July 25, 2014 1:53 pm | Comments

The European Society for Medical Oncology (ESMO) has expressed concern that the proposed EU General Data Protection Regulation could make cancer research impossible and add a significant burden to both doctors and cancer patients.         

TOPICS:

Powerful HIV Antibodies May Require Assist from Second Antibody to Develop

July 25, 2014 1:40 pm | Comments

One strategy for developing a highly effective HIV vaccine is to learn how some HIV-infected people naturally develop antibodies that can stop a high percentage of global HIV strains from infecting human cells in the laboratory. These so-called broadly neutralizing antibodies (bNAbs) develop too late to help infected people overcome the virus.

TOPICS:

New Imaging Agent Provides Better Picture of the Gut

July 25, 2014 1:36 pm | Comments

A multi-institutional team of researchers has developed a new nanoscale agent for imaging the gastrointestinal (GI) tract. This safe, noninvasive method for assessing the function and properties of the GI tract in real time could lead to better diagnosis and treatment of gut diseases.

TOPICS:

Scientists One Step Closer to Stem Cell Therapy for MS

July 25, 2014 1:29 pm | Comments

Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient's own cells.                  

TOPICS:

Key Muscle Component's Atomic Structure Revealed

July 25, 2014 12:54 pm | Comments

In a new study, biophysicists describe– in minute detail- how actin filaments are stabilized at one of their ends to form a basic muscle structure called the sarcomere.                        

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading